1334763-86-8

Basic information

• Product Name: 2-[3-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-pyrazol-1-yl]-N-phenylacetamide
• Synonyms: 2-[3-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-pyrazol-1-yl]-N-phenylacetamide
• CAS NO: 1334763-86-8
• Molecular Weight: 420.473
• Mol File: 1334763-86-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-[3-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-pyrazol-1-yl]-N-phenylacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[3-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-pyrazol-1-yl]-N-phenylacetamide(1334763-86-8)
• EPA Substance Registry System: 2-[3-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-pyrazol-1-yl]-N-phenylacetamide(1334763-86-8)

Safety Data

• Hazardous Substances Data: 1334763-86-8(Hazardous Substances Data)

Upstream product

• 130345-50-5 quinoxaline-6-carbaldehyde 
• 587-65-5 N-chloroacetyl-aniline 
• 1334763-80-2 1-(6-methylpyridin-2-yl)-2-(quinoxalin-6-yl)ethanone 
• 614750-85-5 diphenyl (6-methylpyridin-2-yl)(phenylamino)methylphosphonate 

Downstream Products

• 1334764-05-4 2-[3-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-pyrazol-1-yl]-N-phenylethanethioamide 

Relevant articles and documents

Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin- 2-yl)-4-(quinoxalin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors

A series of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl) pyrazoles 14a-d, 15a-d, 17a, 17b, 18a-d, 19a, and 19b has been synthesized and evaluated for their ALK5 inhibitory activity in an enzyme assay and in a cell-based luciferase reporte